Showing results (171-180 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|November 28, 2018
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trialJung-Kyu Lee, Ji Yeon Lee, Deog Kyeom Kim, et al.
The Lancet. Infectious Diseases|November 27, 2019
Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysisGermán Peñalva, Rocío Fernández-Urrusuno, José María Turmo, et al.
The Lancet. Infectious Diseases|December 2, 2017
Resurgence of scarlet fever in England, 2014-16: a population-based surveillance studyTheresa Lamagni, Rebecca Guy, Meera Chand, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
The Lancet. Infectious Diseases|January 13, 2019
Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak reportVirgie S Fields, Haytham Safi, Catherine Waters, et al.
The Lancet. Infectious Diseases|December 18, 2019
Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveysGünther Fink, Valérie D'Acremont, Hannah H Leslie, et al.
The Lancet. Infectious Diseases|December 22, 2019
Mortality and adverse joint outcomes following septic arthritis of the native knee: a longitudinal cohort study of patients receiving arthroscopic washoutSimon G F Abram, Abtin Alvand, Andrew Judge, et al.
The Lancet. Infectious Diseases|December 24, 2019
HIV infection predominantly affecting children in Sindh, Pakistan, 2019: a cross-sectional study of an outbreakFatima Mir, Faisal Mahmood, Amna Rehana Siddiqui, et al.
The Lancet. Infectious Diseases|December 24, 2019
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trialsJonathon R Campbell, Anete Trajman, Victoria J Cook, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Pageof 269